Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.
Hurtz C, Wertheim GB, Loftus JP, Blumenthal D, Lehman A, Li Y, Bagashev A, Manning B, Cummins KD, Burkhardt JK, Perl AE, Carroll M, Tasian SK.
Hurtz C, et al. Among authors: blumenthal d.
J Clin Invest. 2020 Jul 1;130(7):3637-3653. doi: 10.1172/JCI134424.
J Clin Invest. 2020.
PMID: 32191635
Free PMC article.